Last edition
News about "Prior Approval Supplement "
Heron Therapeutics Announces Acceptance of the PAS Application for ZYNRELEF
Heron Therapeutics, Inc. has announced that the FDA acknowledged the receipt of the company's Prior Approval Supplement (PAS) application for ZYNRELEF (bupivacaine and meloxicam) extended-release solution VAN.
Prior Approval Supplement | 04/07/2024 | By Aishwarya | 199
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members